Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Letter from the Editor
Over the past year we have had a lot of changes in how we interact with our friends, families, and even colleagues. The personal connection of a hug or shaking hands has all but ceased to exist. For lots of folks, this increases stress and feelings of loneliness and isolation. Although we FaceTime and Zoom and have many Teams meetings, it is just not the same. These feelings can cause stress and the release of cortisol in the body. This can lead to an increase in type 2 diabetes, as seen in our Laterpay article from A’Kira Shavers, PharmD Candidate 2021, South College School of Pharmacy. Check out what she has found, and remember to give that extra smile when you are having a Telehealth appointment.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Newsflash: Metformin Reduces COVID-19 Death
Diabetes is associated with an increased risk of contracting COVID-19 and increased risk of death. For those on metformin before a diagnosis of COVID-19, it is associated with reduced odds of related mortality, according to a study published online Jan. 13 in Frontiers in Endocrinology.
See our earlier coverage of metformin and COVID-19.
TOP STORIES — Diabetes News and Research
Loneliness may increase risk for type 2 diabetes, even in patients who are not socially isolated.
Can the diurnal signatures of gastrointestinal microbiota reveal predispositions to diseases such as type 2 diabetes?
An interoperable artificial pancreas system smartphone app was designed, developed, and tested to make decision-making algorithms while running on an unlocked smartphone. An Artificial Pancreas system closes the loop between a continuous glucose monitor (CGM) and an insulin pump by creating an algorithm that adjusts the insulin dose to control blood glucose in patients with type 1 …
Did You Know? Skipping Dinner Tied to Weight Gain
A study in Nutrients found that not eating an evening meal significantly increases the likelihood of ≥10% weight gain and having a body mass index over 25, categorized as overweight/obese. Based on data from 26,433 students, the findings also showed that those who skipped dinner, whether always or occasionally, were more likely to skip other meals more often, have dinner later, have a shorter sleep, and tended to be older and a drinker or a smoker.
The results suggest that skipping dinner, which was much less prevalent than skipping breakfast, has a stronger association with weight gain and overweight/obesity than skipping breakfast, the study said. The researchers suggested that skipping dinner could lead to weight gain because it makes people hungrier, so they eat more over the day. Another possible explanation, they said, is that dinner is typically a meal that lends itself to nutritious foods like lean proteins and vegetables, so skipping dinner may mean a lower quality diet.
Nutrients 2021, 13(1), 271; https://doi.org/10.3390/nu13010271
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Kamilla Avshalum, PharmD Candidate, LECOM School of Pharmacy
Eric Cheung, PharmD Candidate, USF Taneja College of Pharmacy
Shana Indawala, PharmD Candidate, University of South Florida Health, Taneja College of Pharmacy
Melinda Rodriguez, PharmD Candidate 2021, Lake Erie College of Osteopathic Medicine – L|E|C|O|M School of Pharmacy
A’Kira Shavers, PharmD Candidate, South College School of Pharmacy
Mit Suthar, PharmD. Candidate, LECOM School of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com